Surgeons Find low cost statins in aortic aneurysm repair
Dr. McNally and her colleagues studied 401 cases of AAA surgery at their institution. Regardless of these patients had the procedure – if the traditional open approach or endovascular repair, the repair is being made inside and outside the aorta – statin users generally had fewer complications and a lower risk of death after surgery. This result was true even though statin users had health problems more competitive than the control subjects did.About five % of men over age 60 will develop AAA, according to the American Heart Association.
The key is that the optimization of the risk assessment of all patients with AAA repair is imperative, said Dr. McNally. The review could include consideration of their drugs and what they were in the preoperative period.
In addition to Mr. McNally, Steven C. Agle, MD, MPH, Samuel A. Bogey, MD, FACS, Charles S. Powell, MD, FACS, and Michael C. Stoner, MD, FACS, participated in the study.
The next step is for researchers to examine the clinical results behind the reduction in individual costs, and to examine the potentially protective properties of other commonly prescribed cardiovascular medications, including ACE inhibitors and. In addition, these data demonstrate the importance of examining the role of preoperative optimization of the risk logs, databases, and the future prospective studies, said Dr. McNally.
Patients treated with anti-cholesterol statins may have better outcomes and lower costs of the proceedings when a joint operation to repair a bulging of the aorta, according to new research presented at the Annual Meeting of the American College of Clinical 95 surgeons.
We believe that anyone with a diagnosis of abdominal aorta significantly benefit from being on a statin before surgery, said Michael Morgan McNally, MD, co-author of the study the heart of the Institute of East Carolina Brody School of Medicine, East Carolina University in Greenville, North Carolina.
None of the patients on statins in the study died after AAA repair procedure, while five per cent of those not taking statins died after the operation. The study results highlight the risk reduction can be attributed to statins and emphasizes the importance of giving these drugs to patients undergoing cardiovascular procedures, stated Dr. McNally.
These patients should receive statin therapy on as soon as possible, but our study has seen a significant advantage, even after only 30 days on a statin, he said.